![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CD163 |
Gene summary for CD163 |
![]() |
Gene information | Species | Human | Gene symbol | CD163 | Gene ID | 9332 |
Gene name | CD163 molecule | |
Gene Alias | M130 | |
Cytomap | 12p13.31 | |
Gene Type | protein-coding | GO ID | GO:0002526 | UniProtAcc | Q86VB7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9332 | CD163 | HCC1_Meng | Human | Liver | HCC | 8.69e-25 | 7.25e-02 | 0.0246 |
9332 | CD163 | HCC1 | Human | Liver | HCC | 3.33e-04 | 5.06e-01 | 0.5336 |
9332 | CD163 | Pt13.a | Human | Liver | HCC | 3.13e-05 | 2.34e-01 | 0.021 |
9332 | CD163 | Pt13.c | Human | Liver | HCC | 6.33e-12 | 6.58e-01 | 0.0076 |
9332 | CD163 | Pt14.d | Human | Liver | HCC | 3.53e-21 | 5.72e-01 | 0.0143 |
9332 | CD163 | S028 | Human | Liver | HCC | 8.28e-07 | 2.13e-01 | 0.2503 |
9332 | CD163 | S029 | Human | Liver | HCC | 4.49e-03 | 3.13e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00025262 | Liver | HCC | acute inflammatory response | 62/7958 | 112/18723 | 4.06e-03 | 1.77e-02 | 62 |
GO:00069532 | Liver | HCC | acute-phase response | 30/7958 | 49/18723 | 6.31e-03 | 2.57e-02 | 30 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CD163 | SNV | Missense_Mutation | novel | c.310N>A | p.Ala104Thr | p.A104T | Q86VB7 | protein_coding | tolerated(0.37) | benign(0.043) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CD163 | SNV | Missense_Mutation | novel | c.2628C>A | p.Asn876Lys | p.N876K | Q86VB7 | protein_coding | tolerated(0.12) | benign(0.003) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CD163 | SNV | Missense_Mutation | c.3232N>G | p.Arg1078Gly | p.R1078G | Q86VB7 | protein_coding | tolerated(0.14) | benign(0.023) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CD163 | SNV | Missense_Mutation | c.2920C>T | p.Pro974Ser | p.P974S | Q86VB7 | protein_coding | tolerated(1) | benign(0.005) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
CD163 | SNV | Missense_Mutation | c.544A>G | p.Thr182Ala | p.T182A | Q86VB7 | protein_coding | tolerated(0.06) | probably_damaging(0.999) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
CD163 | SNV | Missense_Mutation | c.1756N>A | p.Val586Met | p.V586M | Q86VB7 | protein_coding | tolerated(0.84) | probably_damaging(0.989) | TCGA-D1-A17B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CD163 | SNV | Missense_Mutation | novel | c.2951N>G | p.Phe984Cys | p.F984C | Q86VB7 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
CD163 | SNV | Missense_Mutation | rs373039092 | c.1750N>T | p.Arg584Cys | p.R584C | Q86VB7 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
CD163 | SNV | Missense_Mutation | rs765869382 | c.2158N>T | p.Arg720Cys | p.R720C | Q86VB7 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-DF-A2KV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CD163 | SNV | Missense_Mutation | rs771306546 | c.2753N>T | p.Ser918Leu | p.S918L | Q86VB7 | protein_coding | tolerated(0.06) | possibly_damaging(0.513) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
9332 | CD163 | DRUGGABLE GENOME, KINASE, EXTERNAL SIDE OF PLASMA MEMBRANE | GLUCOCORTICOID | 9712057 | ||
9332 | CD163 | DRUGGABLE GENOME, KINASE, EXTERNAL SIDE OF PLASMA MEMBRANE | FLUTICASONE PROPIONATE | 9712057 |
Page: 1 |